Current Antipsychotics

1. The Dopamine Dysfunction in Schizophrenia Revisited: New Insights into Topography and Course
Rebecca Kuepper, Mette Skinbjerg, Anissa Abi-Dargham

2. Role of Dopamine D2 Receptors for Antipsychotic Activity
Nathalie Ginovart, Shitij Kapur

3. Dopamine Receptor Signaling and Current and Future Antipsychotic Drugs
Kevin N. Boyd, Richard B. Mailman

4. Serotonergic Mechanisms as Targets for Existing and Novel Antipsychotics
Herbert Y. Meltzer

5. Managing the Prodrome of Schizophrenia
W. Wolfgang Fleischhacker, Alexander M. Simma

6. Metabolic Consequences of Antipsychotic Therapy: Preclinical and Clinical Perspectives on Diabetes, Diabetic Ketoacidosis, and Obesity
David J. Heal, Jane Gosden, Helen C. Jackson, Sharon C. Cheetham, Sharon L. Smith

7. Medical Needs in the Treatment of Psychotic Disorders
F. Markus Leweke, Thorsten M. Odorfer, J. Malte Bumb

8. Antipsychotics in the Treatment of Bipolar Disorder
Jaskaran Singh, Guang Chen, Carla M. Canuso

9. The Pharmacogenetics of Antipsychotic Treatment
Gavin P. Reynolds

10. Interactions and Monitoring of Antipsychotic Drugs
Christoph Hiemke, Bruno Pfuhlmann

11. Delivery Systems and Dosing for Antipsychotics
Cara R. Rabin, Steven J. Siegel

12. Imaging as Tool to Investigate Psychoses and Antipsychotics
Jan Booij, Thérèse Amelsvoort

13. Biomarkers for Antipsychotic Therapies
Emilio Merlo Pich, Gabriel Vargas, Enrico Domenici

14. Behavioral Animal Models of Antipsychotic Drug Actions
Daria Peleg-Raibstein, Joram Feldon, Urs Meyer

Avainsanat: Biomedicine, Pharmacology/Toxicology, Neurosciences, Receptors, Neurobiology, Behavioural Sciences, Pharmacy